title: Cost-Utility Analysis (cua) Of First-Line Disease-Modifying Treatments (DMT) Versus Best Supportive Care (Bsc) In Finnish Relapsing-Remitting Multiple Sclerosis (RRMS) Patients.
authors.affiliation: ESiOR Oy, Kuopio, Finland.
authors.forename: E
authors.initials: E
authors.lastname: Soini
authors.affiliation: ESiOR Oy, Kuopio, Finland.
authors.forename: C
authors.initials: C
authors.lastname: Asseburg
authors.affiliation: School of Medicine, University of Tampere, Finland.
authors.forename: M L
authors.initials: ML
authors.lastname: Sumelahti